Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen
Erlangen, Bayern, Germany
1130: Safety of Bispecific T-cell Engager Therapy in Autoimmune Disease
Sunday, November 17, 2024
10:30 AM – 12:30 PM Eastern Time
No financial relationships with ineligible companies to disclose